XBIO financials

Xenetic Biosciences (XBIO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

XBIO income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$2.98M–-$2.83M-$2.68M-1.58
2024$2.50M–-$4.20M-$3.96M-2.57
2023$2.54M–-$4.52M-$4.13M-2.71
2022$1.71M–-$6.72M-$6.55M-4.61
2021$1.16M–-$5.75M-$5.65M-5.50
2020$436.94K–-$13.94M-$10.89M-17.00